Medulloblastoma Clinical Trials 2022

Medulloblastoma studies recruiting patients for novel treatments. Filter by phase, distance, and inclusion criteria to find your perfect medulloblastoma clinical trial in 2022.

Phase-Based Estimates
1
Effectiveness
2
Safety

[18F]DPA714for Neoplasms, Brain

Phase 2
Recruiting
Memphis, TN
< 65
All Sexes
Phase-Based Estimates
1
Effectiveness
2
Safety

Partial Radiationfor Glioblastoma

Phase 2
Recruiting
Druid Hills, GA
< 65
All Sexes
Phase-Based Estimates
1
Effectiveness
1
Safety

Cyclophosphamidefor Medulloblastoma

Phase 1
Waitlist Available
Memphis, TN
< 65
All Sexes
Phase-Based Estimates
1
Effectiveness
1
Safety

EGFR806-specific Chimeric Antigen Receptor (CAR) T Cellfor Central Nervous System Neoplasms

Phase 1
Recruiting
Seattle, WA
< 65
All Sexes
Phase-Based Estimates
1
Effectiveness
1
Safety

HER2-specific Chimeric Antigen Receptor (CAR) T Cellfor Central Nervous System Neoplasms

Phase 1
Recruiting
Seattle, WA
< 65
All Sexes
Phase-Based Estimates
1
Effectiveness
1
Safety

Gemcitabinefor Neoplasms, Brain

Phase 1
Recruiting
Memphis, TN
< 65
All Sexes
Phase-Based Estimates
1
Effectiveness
2
Safety

Nivolumabfor Choroid Plexus Neoplasms

Phase 2
Recruiting
Evanston, IL
18+
All Sexes
Phase-Based Estimates
1
Effectiveness
1
Safety

SurVaxM For Patients With Relapsed Or Progressive MB, HGG Or Ependymoma Ages ≥1 And <10 Yearsfor High-grade Astrocytoma NOS

Phase 1
Recruiting
New York, NY
< 65
All Sexes
Phase-Based Estimates
1
Effectiveness
2
Safety

Neurocognitive Remediationfor Medulloblastoma

Phase 2
Recruiting
Memphis, TN
< 65
All Sexes
Phase-Based Estimates
1
Effectiveness
1
Safety

SCRI-CARB7H3(s); B7H3-specific Chimeric Antigen Receptor (CAR) T Celfor Central Nervous System Neoplasms

Phase 1
Recruiting
Seattle, WA
< 65
All Sexes